$USNA Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of -$1.16 down -323.08% YoY
• Reported revenue of $223.27M down -5.33% YoY
• USANA Health Sciences updated its fiscal year 2026 outlook, now expecting consolidated net sales of $910 million, a net loss of $(11) million, and adjusted diluted EPS of $0.76.